Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Oncotarget|October 8, 2016
Ran GTPase promotes cancer progression via Met recepto-rmediated downstream signalingHiu-Fung Yuen, Ka-Kui Chan, Angela Platt-Higgins, et al.
The American Journal of Pathology|June 22, 2011
The role of Pea3 group transcription factors in esophageal squamous cell carcinomaHiu-Fung Yuen, Cian M McCrudden, Ka-Kui Chan, et al.
Autophagy|August 20, 2014
A role of autophagy in PTP4A3-driven cancer progressionYu-Han Huang, Abdul Qader O Al-Aidaroos, Hiu-Fung Yuen, et al.
The Journal of Pathology|March 16, 2011
Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transitionHiu-Fung Yuen, Yuen-Kwong Chan, Claire Grills, et al.
Cancer Science|February 28, 2012
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progressionHiu-Fung Yuen, Cian M McCrudden, Claire Grills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer ChemoresistanceBin Li, Wen Wen Xu, Xin Yuan Guan, et al.
Plos One|February 18, 2015
Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itselfCian M McCrudden, Martin G O'Rourke, Kim E Cherry, et al.
Oncotarget|April 19, 2017
Erythropoietin drives breast cancer progression by activation of its receptor EPORKa Kui Chan, Kyle B Matchett, Jonathan A Coulter, et al.
JCI Insight|October 5, 2016
PRL3-zumab, a first-in-class humanized antibody for cancer therapyMin Thura, Abdul Qader Omer Al-Aidaroos, Wei Peng Yong, et al.
Pageof 4